Decreased glial cell line-derived neurotrophic factor levels in patients with depression: A meta-analytic study

Journal of Psychiatric Research

Volumn 63, Issue , 2015, Pages 20-27

  Lin, Pao Yen ^a,b   Tseng, Ping Tao ^c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Tsyr Huey Mental Hospital   (Taiwan)

Author keywords

Depression; GDNF; Major depression; Meta analysis

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ARTICLE; DEPRESSION; EFFECT SIZE; GENDER; HUMAN; MAJOR DEPRESSION; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHIATRIC DIAGNOSIS; SENESCENCE; AGE; BLOOD; FEMALE; MALE; MEDLINE; META ANALYSIS; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; PUBMED;

EID: 84926408562     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.02.004     Document Type: Article

References (55)

1. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002, 3:383-394.
2. Barbosa I.G., Huguet R.B., Sousa L.P., Abreu M.N., Rocha N.P., Bauer M.E., et al. Circulating levels of GDNF in bipolar disorder. Neurosci Lett 2011, 502:103-106.
3. Berent D., Macander M., Szemraj J., Orzechowska A., Galecki P. Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins. Acta Neurobiol Exp (Wars) 2014, 74:82-90.
4. Bittner S., Ruck T., Fernandez-Orth J., Meuth S.G. TREK-king the blood-brain-barrier. JNeuroimmune Pharmacol 2014, 9:293-301.
5. Blasko I., Lederer W., Oberbauer H., Walch T., Kemmler G., Hinterhuber H., et al. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 2006, 21:9-15.
6. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M.G., Placentino A., et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 2010, 11:763-773.
7. Christophersen N.S., Gronborg M., Petersen T.N., Fjord-Larsen L., Jorgensen J.R., Juliusson B., et al. Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Exp Neurol 2007, 204:791-801.
8. de Azevedo Cardoso T., Mondin T.C., Wiener C.D., Marques M.B., Fucolo Bde A., Pinheiro R.T., et al. Neurotrophic factors, clinical features and gender differences in depression. Neurochem Res 2014, 39:1571-1578.
9. Diniz B.S., Teixeira A.L., Miranda A.S., Talib L.L., Gattaz W.F., Forlenza O.V. Circulating Glial-derived neurotrophic factor is reduced in late-life depression. JPsychiatr Res 2012, 46:135-139.
10. Dmitrzak-Weglarz M., Skibinska M., Slopien A., Tyszkiewicz M., Pawlak J., Maciukiewicz M., et al. Serum neurotrophin concentrations in polish adolescent girls with anorexia nervosa. Neuropsychobiology 2013, 67:25-32.
11. Ducray A., Krebs S.H., Schaller B., Seiler R.W., Meyer M., Widmer H.R. GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res 2006, 1069:104-112.
12. Duman R.S., Li N. Aneurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci 2012, 367:2475-2484.
13. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997, 315:629-634.
14. Fontenelle L.F., Barbosa I.G., Luna J.V., Rocha N.P., Silva Miranda A., Teixeira A.L. Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 2012, 199:195-200.
15. Fornaro M., Rocchi G., Escelsior A., Contini P., Ghio M., Colicchio S., et al. VEGF plasma level variations in duloxetine-treated patients with major depression. JAffect Disord 2013, 151:590-595.
16. Golden J.P., Baloh R.H., Kotzbauer P.T., Lampe P.A., Osborne P.A., Milbrandt J., et al. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. JComp Neurology 1998, 398:139-150.
17. Greden J.F. The burden of recurrent depression: causes, consequences, and future prospects. JClin Psychiatry 2001, 62(Suppl.22):5-9.
18. Heberlein A., Lenz B., Muschler M., Frieling H., Buechl R., Groschl M., et al. BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence. Psychopharmacol Berl 2010, 209:213-215.
19. Hochstrasser T., Ullrich C., Sperner-Unterweger B., Humpel C. Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience 2011, 184:128-138.
20. Jaumotte J.D., Zigmond M.J. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures. JNeurosci Res 2014, 92:1425-1433.
21. Kastin A.J., Akerstrom V., Pan W. Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neurosci Lett 2003, 340:239-241.
22. Kotyuk E., Keszler G., Nemeth N., Ronai Z., Sasvari-Szekely M., Szekely A. Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety. PLoS One 2013, 8:e80613.
23. Kotyuk E., Nemeth N., Halmai Z., Faludi G., Sasvari-Szekely M., Szekely A. Association between mood characteristics and polymorphisms of glial cell line-derived neurotrophic factor (GNDF) in patients with depression. Neuropsychopharmacol Hung 2013, 15:63-72.
24. Li X., Wilder-Smith C.H., Kan M.E., Lu J., Cao Y., Wong R.K. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation. Neuro Endocrinol Lett 2014, 35:58-63.
25. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
26. Lundborg C., Hahn-Zoric M., Biber B., Hansson E. Glial cell line-derived neurotrophic factor is increased in cerebrospinal fluid but decreased in blood during long-term pain. JNeuroimmunol 2010, 220:108-113.
27. Ma X.C., Chen C., Zhu F., Jia W., Gao C.G. Association of the GDNF gene with depression and heroin dependence, but not schizophrenia, in a Chinese population. Psychiatry Res 2013, 210:1296-1298.
28. Marksteiner J., Kemmler G., Weiss E.M., Knaus G., Ullrich C., Mechtcheriakov S., et al. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2011, 32:539-540.
29. Michel T.M., Frangou S., Camara S., Thiemeyer D., Jecel J., Tatschner T., et al. Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry 2008, 23:413-420.
30. Molendijk M.L., Spinhoven P., Polak M., Bus B.A., Penninx B.W., Elzinga B.M. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol Psychiatry 2014, 19:791-800.
31. Najjar S., Pearlman D.M., Devinsky O., Najjar A., Zagzag D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. JNeuroinflammation 2013, 10:142.
32. Ortiz-Ortiz M.A., Moran J.M., Ruiz-Mesa L.M., Bonmatty R.G., Fuentes J.M. Protective effect of the glial cell line-derived neurotrophic factor (GDNF) on human mesencephalic neuron-derived cells against neurotoxicity induced by paraquat. Environ Toxicol Pharmacol 2011, 31:129-136.
33. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., et al. Altered expression of neurotrophic factors in patients with major depression. JPsychiatr Res 2008, 42:1145-1153.
34. Pallavi P., Sagar R., Mehta M., Sharma S., Subramanium A., Shamshi F., et al. Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. JAffect Disord 2013, 150:415-423.
35. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gomez-Diaz R., Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci 2008, 11:755-761.
36. Ricci V., Pomponi M., Martinotti G., Bentivoglio A., Loria G., Bernardini S., et al. Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. JClin Psychopharmacol 2010, 30:751-753.
37. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 2006, 407:146-150.
38. Rybakowski J.K., Permoda-Osip A., Skibinska M., Adamski R., Bartkowska-Sniatkowska A. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?. Hum Psychopharmacol 2013, 28:87-90.
39. Shadish W.R., Haddock C.K. Combining estimates of effect size. The handbook of research synthesis 1994, 261-281. Russell Sage foundation, New York. H. Cooper, L.V. Hedges (Eds.).
40. Sievers C., Auer M.K., Klotsche J., Athanasoulia A.P., Schneider H.J., Nauck M., et al. IGF-I levels and depressive disorders: results from the Study of Health in Pomerania (SHIP). Eur Neuropsychopharmacol 2014, 24:890-896.
41. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. Jama 2000, 283:2008-2012.
42. Sun H., Zhao H., Ma C., Bao F., Zhang J., Wang D.H., et al. Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study. JAltern Complement Med 2013, 19:733-739.
43. Takaku S., Yanagisawa H., Watabe K., Horie H., Kadoya T., Sakumi K., et al. GDNF promotes neurite outgrowth and upregulates galectin-1 through the RET/PI3K signaling in cultured adult rat dorsal root ganglion neurons. Neurochem Int 2013, 62:330-339.
44. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol 2006, 9:607-612.
45. Tseng P.T., Lee Y., Lin P.Y. Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2013, 40:334-339.
46. Uzdensky A., Komandirov M., Fedorenko G., Lobanov A. Protection effect of GDNF and neurturin on photosensitized crayfish neurons and glial cells. JMol Neurosci 2013, 49:480-490.
47. Wakeman D.R., Redmond D.E., Dodiya H.B., Sladek J.R., Leranth C., Teng Y.D., et al. Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target. Stem Cells Transl Med 2014, 3:692-701.
48. Wang X., Hou Z., Yuan Y., Hou G., Liu Y., Li H., et al. Association study between plasma GDNF and cognitive function in late-onset depression. JAffect Disord 2011, 132:418-421.
49. Wang X.C., Xu D.J., Chen G.H., Xia Q., Liu L.N. Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a chinese population. Ther Drug Monit 2014, 36:612-617.
50. Weber-Hamann B., Blum W.F., Kratzsch J., Gilles M., Heuser I., Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry 2009, 42:23-28.
51. Yosef N., Ubogu E.E. GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization. Microvasc Res 2012, 83:298-310.
52. Zhang X., Ru B., Sha W., Xin W., Zhou H., Zhang Y. Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder. Asia Pac Psychiatry 2014, 6:302-307.
53. Zhang X., Zhang Z., Sha W., Xie C., Xi G., Zhou H., et al. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Res 2009, 170:273-275.
54. Zhang X., Zhang Z., Sha W., Xie C., Xi G., Zhou H., et al. Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. JAffect Disord 2010, 126:326-329.
55. Zhang X., Zhang Z., Xie C., Xi G., Zhou H., Zhang Y., et al. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:886-890.